Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparing a Standard of Care Prostate Biopsy System With a Novel System Using Standard as Well as Computational Pathology Analyses to Measure Clinical and Morphometric Parameters.

NCT06830265 is registered in ClinicalTrials.gov with Uro-1 Medical as lead sponsor.

NCT NCT06830265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06830265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparing a Standard of Care Prostate Biopsy System With a Novel System Using Standard as Well as Computational Pathology Analyses to Measure Clinical and Morphometric Parameters.
Lead sponsor
Uro-1 Medical
Phase
Not applicable
Overall status
Recruiting
Start date
July 7, 2025
Completion date
December 10, 2026
Enrollment
200 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer screening